Pre-hospital rule-out of non-ST-segment elevation acute coronary syndrome by a single troponin: final one-year outcomes of the ARTICA randomised trial.
Goaris W A AartsCyril CamaroEddy M M AdangLaura RodwellRoger van HoutGijs BrokAnouk HoareFrank de PooterWalter de WitGilbert E CramerRoland R J van KimmenadeEva OuwendijkMartijn G S RuttenErwin ZegersRobert-Jan M van GeunsMarc E R GomesPeter DammanNiels van RoyenPublished in: European heart journal. Quality of care & clinical outcomes (2024)
Pre-hospital rule-out of NSTE-ACS with POC troponin testing in low-risk patients is cost-effective, as expressed by a sustainable healthcare cost reduction and no significant effect on QoL. One-year MACE remained low for both strategies.
Keyphrases
- acute coronary syndrome
- healthcare
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- percutaneous coronary intervention
- adverse drug
- peritoneal dialysis
- study protocol
- type diabetes
- metabolic syndrome
- coronary artery disease
- patient reported outcomes
- open label
- atrial fibrillation
- insulin resistance
- health information
- electronic health record